Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2022 Results Presentation

Presentation and Q&A session scheduled for post-market on Wednesday, March 1, 2023 BOSTON, Feb. 22, 2023 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A…

About the Author

has written 41552 stories on this site.

Copyright © 2010 Business and Corporate News.